FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
-2.65%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+2.8%)
Cap. Flow
+$9.01M
Cap. Flow
% of AUM
5.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$7.08M |
| 2 |
Pharvaris
PHVS
|
$1.93M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pharvaris
PHVS
$1.39B
| $81.4M | 53.23% | 4,397,881 +104,027 | +2% | +$1.93M |
|
2
Kura Oncology
KURA
$686M
| $36.1M | 23.62% | 1,849,947 | – | – |
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $16.8M | 11.01% | 875,000 | – | – |
|
4
Lyell Immunopharma
LYEL
$213M
| $11.5M | 7.51% | 8,325,000 | – | – |
|
|
5
Relay Therapeutics
RLAY
$619M
| $7.08M | 4.63% | +1,000,000 | New | +$7.08M |
|